Cisplatin plus gemcytabine versus cisplatin plus vinorelbine in patients with stage IV nonsmall cell lung cancer (NSCLC): Results of single center experience

被引：1
|
作者：
Er, O
Ozkan, M
Coskun, S
Dogu, G
Altinbas, M
机构：
[1] Erciyes Univ, Fac Med, MK Dedeman Oncol Hosp, Kayseri, Turkey
[2] Suleyman Demirel Univ, Fac Med, Isparta, Turkey
来源：
LUNG CANCER | 2005年 / 49卷
关键词：
D O I：
10.1016/S0169-5002(05)80974-2
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S243 / S243
页数：1
相关论文
共 50 条
  • [1] Vinorelbine and oxaliplatin in stage IV nonsmall cell lung cancer patients unfit for cisplatin: a single-center experience
    Mir, Olivier
    Alexandre, Jerome
    Ropert, Stanislas
    Montheil, Vincent
    Martin, Idalie
    Durand, Jean-Philippe
    Goldwasser, Francois
    ANTI-CANCER DRUGS, 2009, 20 (02) : 105 - 108
  • [2] VINORELBINE VERSUS VINORELBINE PLUS CISPLATIN IN ADVANCED NONSMALL CELL LUNG-CANCER - A RANDOMIZED TRIAL
    DEPIERRE, A
    CHASTANG, C
    QUOIX, E
    LEBEAU, B
    BLANCHON, F
    PAILLOT, N
    LEMARIE, E
    MILLERON, B
    MORO, D
    CLAVIER, J
    HERMAN, D
    TUCHAIS, E
    JACOULET, P
    BRECHOT, JM
    CORDIER, JF
    SOLALCELIGNY, P
    BADRI, N
    BESENVAL, M
    ANNALS OF ONCOLOGY, 1994, 5 (01) : 37 - 42
  • [3] Cost-effectiveness of vinorelbine alone or vinorelbine plus cisplatin for stage IV NSCLC
    Evans, WK
    ONCOLOGY-NEW YORK, 1998, 12 (03): : 18 - 26
  • [4] A single centre experience of cisplatin and vinorelbine in stage IIIA-IV non small cell lung cancer, (NSCLC)
    White, J
    Glen, H
    Anthoney, A
    O'Rouke, N
    Dunlop, DJ
    BRITISH JOURNAL OF CANCER, 2002, 86 : S60 - S60
  • [5] Randomized, double-blind phase II study to compare nitroglycerin plus oral vinorelbine plus cisplatin with oral vinorelbine plus cisplatin alone in patients with stage IIIB/IV non-small cell lung cancer (NSCLC)
    Reinmuth, N.
    Meyer, A.
    Hartwigsen, D.
    Schaeper, C.
    Huebner, G.
    Skock-Lober, R.
    Bier, A.
    Gerecke, U.
    Held, C. -P.
    Reck, M.
    LUNG CANCER, 2014, 83 (03) : 363 - 368
  • [6] A 3-ARM TRIAL OF VINORELBINE (NAVELBINE) PLUS CISPLATIN, VINDESINE PLUS CISPLATIN, AND SINGLE-AGENT VINORELBINE IN THE TREATMENT OF NONSMALL CELL LUNG-CANCER - AN EXPANDED ANALYSIS
    LECHEVALIER, T
    PUJOL, JL
    DOUILLARD, JY
    ALBEROLA, V
    MONNIER, A
    RIVIERE, A
    LIANES, P
    CHOMY, P
    CIGOLARI, S
    BESSON, F
    BERTHAUD, P
    BRISGAND, D
    BURRIS, HA
    LIVINGSTON, RB
    GRALLA, R
    COLTMAN, CA
    SEMINARS IN ONCOLOGY, 1994, 21 (05) : 28 - 34
  • [7] Gemcitabine plus cisplatin versus gemcitabine plus vinorelbine in the treatment of advanced non-small cell lung cancer (NSCLC).
    Zhang, Y
    Zhang, L
    Li, N
    Xu, F
    Pan, ZK
    Guang, ZZ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 702S - 702S
  • [8] The effectiveness of vinorelbine plus cisplatin versus gemcitabine plus cisplatin in local advanced non-small cell lung cancer
    Koemuercueoglu, B.
    Aydogan, H.
    Tekguel, S.
    Cecen, E.
    Yalniz, E.
    Oezden, E. Pala
    LUNG CANCER, 2006, 52 : S36 - S36
  • [9] Analysis of the costs of bevacizumab plus cisplatin and gemcitabine versus cetuximab plus vinorelbine and cisplatin in patients with advanced non-small cell lung cancer (NSCLC) in France: Results from a cost modelling study
    Chouaid, C.
    Vergnenegre, A.
    Florentin, V.
    Walzer, S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [10] A prospective randomized study of a sequence of cisplatin plus vinorelbine and ifosfamide plus epirubicin versus the reverse sequence in stage III-IV non-small cell lung cancer (NSCLC)
    Colucci, G
    Gebbia, V
    Galetta, D
    Riccardi, F
    Scoditti, S
    Toma, P
    Cariello, S
    Pezzella, G
    Durini, E
    Lorenzo, R
    Pandolfo, G
    2ND INTERNATIONAL CONGRESS ON LUNG CANCER, 1996, : 497 - 501
12345